|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
nucleus
|
1 term
|
 |
|
Biological process
|
regulation of transcription
|
2 terms
|
 |
|
Biochemical function
|
transcription factor activity
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
277:24694-24700
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
The x-ray crystal structure of the NF-kappa B p50.p65 heterodimer bound to the interferon beta -kappa B site.
|
|
B.Berkowitz,
D.B.Huang,
F.E.Chen-Park,
P.B.Sigler,
G.Ghosh.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
We have determined the x-ray crystal structure of the transcription factor
NF-kappaB p50.p65 heterodimer complexed to kappaB DNA from the cytokine
interferon beta enhancer (IFNbeta-kappaB). To better understand how the binding
modes of NF-kappaB on its two best studied DNA targets might contribute to
promoter-specific transcription, this structure is compared with the previously
determined complex crystal structure containing NF-kappaB bound to the Ig kappa
light chain gene enhancer as well as to a second NF-kappaB.Ig kappa light chain
gene enhancer complex also reported in this paper. The global binding modes of
all NF-kappaB.DNA complex structures are similar, although crystal-packing
interactions lead to differences between identical complexes of the same
crystallographic asymmetric unit. An extensive network of stacked amino acid
side chains that contribute to base-specific DNA contacts is conserved among the
three complexes. Consistent with earlier reports, however, the IFNbeta-kappaB
DNA is bent significantly less by NF-kappaB than is the Ig kappa light chain
gene enhancer. This and other small structural changes may play a role in
explaining why NF-kappaB-directed transcription is sensitive to the context of
specific promoters. The precise molecular mechanism behind the involvement of
the high mobility group protein I(Y) in interferon beta enhanceosome formation
remains elusive.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Fig. 1. Schematic of the Rel homology region p50 and p65
and B DNA
sequences. a, the RHR of p50 and p65 contain amino- and
carboxyl-terminal domains ( CTD) linked by a short linker
sequence. The numbering corresponds to murine p50 (depicted in
yellow) and murine p65 (shown in green). b, the B DNA
sequences referred to in this study are shown. The structures of
NF- B
co-crystals with PRDII (IFN - B) and
Ig/HIV-2 sequences are described in detail. The Ig/HIV-1
sequence was used in our previous study (8). Shown for
comparison are the uPA- B and
CD28RE sites. CD28RE contains a 9-base pair consensus sequence
and binds optimally to p65 and c-Rel homodimers. Consensus B DNA
sequences are underlined. The two B DNA
half-sites are indicated by positive and negative numbering with
the position 0 corresponding to a central nucleotide base pair
that passes through the pseudodyad axis of the
protein·DNA complex.
|
 |
Figure 2.
Fig. 2. The structure of the IFN - B·p50·p65
heterodimer complex. a, the two complexes in the asymmetric
unit. The p50 and p65 subunits are shown in yellow and green,
respectively. The DNA strands are shown as orange and cyan
spheres. b, the crystallographic contacts between complex 1 and
a symmetrical complex. c, the entire complex is viewed down the
DNA axis. p50 and p65 subunits are indicated by yellow and
green, respectively. d, the detailed interactions across the
subunit interface centered around Tyr-267 of p50 and Phe-213 of
p65.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2002,
277,
24694-24700)
copyright 2002.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.S.Manuvakhova,
G.G.Johnson,
M.C.White,
S.Ananthan,
M.Sosa,
C.Maddox,
S.McKellip,
L.Rasmussen,
K.Wennerberg,
J.V.Hobrath,
E.L.White,
J.A.Maddry,
and
M.Grimaldi
(2011).
Identification of novel small molecule activators of nuclear factor-κB with neuroprotective action via high-throughput screening.
|
| |
J Neurosci Res, 89,
58-72.
|
 |
|
|
|
|
 |
F.L.Sinquett,
R.L.Dryer,
V.Marcelli,
A.Batheja,
and
L.R.Covey
(2009).
Single nucleotide changes in the human Igamma1 and Igamma4 promoters underlie different transcriptional responses to CD40.
|
| |
J Immunol, 182,
2185-2193.
|
 |
|
|
|
|
 |
J.C.Stroud,
A.Oltman,
A.Han,
D.L.Bates,
and
L.Chen
(2009).
Structural basis of HIV-1 activation by NF-kappaB--a higher-order complex of p50:RelA bound to the HIV-1 LTR.
|
| |
J Mol Biol, 393,
98.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Bergqvist,
V.Alverdi,
B.Mengel,
A.Hoffmann,
G.Ghosh,
and
E.A.Komives
(2009).
Kinetic enhancement of NF-kappaBxDNA dissociation by IkappaBalpha.
|
| |
Proc Natl Acad Sci U S A, 106,
19328-19333.
|
 |
|
|
|
|
 |
T.Huxford,
and
G.Ghosh
(2009).
A structural guide to proteins of the NF-kappaB signaling module.
|
| |
Cold Spring Harbor Perspect Biol, 1,
a000075.
|
 |
|
|
|
|
 |
C.R.Escalante,
E.Nistal-Villán,
L.Shen,
A.García-Sastre,
and
A.K.Aggarwal
(2007).
Structure of IRF-3 bound to the PRDIII-I regulatory element of the human interferon-beta enhancer.
|
| |
Mol Cell, 26,
703-716.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Wietek,
and
L.A.O'Neill
(2007).
Diversity and regulation in the NF-kappaB system.
|
| |
Trends Biochem Sci, 32,
311-319.
|
 |
|
|
|
|
 |
D.K.Langat,
P.J.Morales,
C.O.Omwandho,
and
A.T.Fazleabas
(2007).
Polymorphisms in the Paan-AG promoter influence NF-kappaB binding and transcriptional activity.
|
| |
Immunogenetics, 59,
359-366.
|
 |
|
|
|
|
 |
D.Panne,
T.Maniatis,
and
S.C.Harrison
(2007).
An atomic model of the interferon-beta enhanceosome.
|
| |
Cell, 129,
1111-1123.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Hoffmann,
G.Natoli,
and
G.Ghosh
(2006).
Transcriptional regulation via the NF-kappaB signaling module.
|
| |
Oncogene, 25,
6706-6716.
|
 |
|
|
|
|
 |
M.L.Schmitz,
and
D.Krappmann
(2006).
Controlling NF-kappaB activation in T cells by costimulatory receptors.
|
| |
Cell Death Differ, 13,
834-842.
|
 |
|
|
|
|
 |
Y.Sasuga,
T.Tani,
M.Hayashi,
H.Yamakawa,
O.Ohara,
and
Y.Harada
(2006).
Development of a microscopic platform for real-time monitoring of biomolecular interactions.
|
| |
Genome Res, 16,
132-139.
|
 |
|
|
|
|
 |
A.S.Romanenkov,
A.A.Ustyugov,
T.S.Zatsepin,
A.A.Nikulova,
I.V.Kolesnikov,
V.G.Metelev,
T.S.Oretskaya,
and
E.A.Kubareva
(2005).
Analysis of DNA-protein interactions in complexes of transcription factor NF-kappaB with DNA.
|
| |
Biochemistry (Mosc), 70,
1212-1222.
|
 |
|
|
|
|
 |
R.Caliandro,
B.Carrozzini,
G.L.Cascarano,
L.De Caro,
C.Giacovazzo,
and
D.Siliqi
(2005).
Phasing at resolution higher than the experimental resolution.
|
| |
Acta Crystallogr D Biol Crystallogr, 61,
556-565.
|
 |
|
|
|
|
 |
Y.Han,
J.A.Englert,
R.L.Delude,
and
M.P.Fink
(2005).
Ethacrynic acid inhibits multiple steps in the NF-kappaB signaling pathway.
|
| |
Shock, 23,
45-53.
|
 |
|
|
|
|
 |
D.Panne,
T.Maniatis,
and
S.C.Harrison
(2004).
Crystal structure of ATF-2/c-Jun and IRF-3 bound to the interferon-beta enhancer.
|
| |
EMBO J, 23,
4384-4393.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Crinelli,
M.Bianchi,
L.Gentilini,
L.Palma,
M.D.Sørensen,
T.Bryld,
R.B.Babu,
K.Arar,
J.Wengel,
and
M.Magnani
(2004).
Transcription factor decoy oligonucleotides modified with locked nucleic acids: an in vitro study to reconcile biostability with binding affinity.
|
| |
Nucleic Acids Res, 32,
1874-1885.
|
 |
|
|
|
|
 |
S.Zelivianski,
R.Glowacki,
and
M.F.Lin
(2004).
Transcriptional activation of the human prostatic acid phosphatase gene by NF-kappaB via a novel hexanucleotide-binding site.
|
| |
Nucleic Acids Res, 32,
3566-3580.
|
 |
|
|
|
|
 |
T.H.Leung,
A.Hoffmann,
and
D.Baltimore
(2004).
One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers.
|
| |
Cell, 118,
453-464.
|
 |
|
|
|
|
 |
A.Hoffmann,
T.H.Leung,
and
D.Baltimore
(2003).
Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities.
|
| |
EMBO J, 22,
5530-5539.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|